chrX-14690789-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The NM_002063.4(GLRA2):c.1010C>T(p.Ala337Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000459 in 1,197,991 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000049 ( 0 hom. 17 hem. )
Consequence
GLRA2
NM_002063.4 missense
NM_002063.4 missense
Scores
2
7
8
Clinical Significance
Conservation
PhyloP100: 4.80
Genes affected
GLRA2 (HGNC:4327): (glycine receptor alpha 2) The glycine receptor consists of two subunits, alpha and beta, and acts as a pentamer. The protein encoded by this gene is an alpha subunit and can bind strychnine. Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.37280753).
BP6
Variant X-14690789-C-T is Benign according to our data. Variant chrX-14690789-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3281628.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-14690789-C-T is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAdExome4 at 17 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLRA2 | NM_002063.4 | c.1010C>T | p.Ala337Val | missense_variant | 8/9 | ENST00000218075.9 | NP_002054.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLRA2 | ENST00000218075.9 | c.1010C>T | p.Ala337Val | missense_variant | 8/9 | 1 | NM_002063.4 | ENSP00000218075 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000181 AC: 2AN: 110595Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32831
GnomAD3 genomes
AF:
AC:
2
AN:
110595
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
32831
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000382 AC: 7AN: 183371Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67821
GnomAD3 exomes
AF:
AC:
7
AN:
183371
Hom.:
AF XY:
AC XY:
2
AN XY:
67821
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000487 AC: 53AN: 1087344Hom.: 0 Cov.: 29 AF XY: 0.0000481 AC XY: 17AN XY: 353094
GnomAD4 exome
AF:
AC:
53
AN:
1087344
Hom.:
Cov.:
29
AF XY:
AC XY:
17
AN XY:
353094
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000181 AC: 2AN: 110647Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32893
GnomAD4 genome
AF:
AC:
2
AN:
110647
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
32893
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;L;L
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
0.84, 0.023
.;P;B
Vest4
MVP
MPC
2.2
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at